TEVA PHARMACEUTICALS USA

• TEVA PHARMACEUTICALS USA, INC. $4,310,000 In-house, the client's own filings · 7 filings
• MR. DAVID FRIEDMAN $600,000 Outside firm · 5 filings
• FAEGRE DRINKER BIDDLE & REATH LLP $420,000 Outside firm · 7 filings
• CAPITOL HILL CONSULTING GROUP $380,000 Outside firm · 7 filings
• TALLEY STRATEGIES LLC $160,000 Outside firm · 6 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 1843
  To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
  7 filings
• S.J. Res. 37
  A joint resolution terminating the national emergency declared to impose duties on articles imported from Can…
  7 filings
• H.R. 6888
  Trump Tariff Transparency Act
  4 filings
• S. 959
  Tariff Transparency Act of 2025
  4 filings

• 2026 $2,570,000 15 filings
• 2025 $3,300,000 17 filings

• Health Issues 24
• Copyright/Patent/Trademark 7
• Medicare/Medicaid 7
• Tariff (miscellaneous tariff bills) 7
• Trade (domestic/foreign) 7
• Pharmacy 6
• Manufacturing 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 23
• SENATE 23
• Health & Human Services, Dept of (HHS) 12
• Commerce, Dept of (DOC) 11
• Centers For Medicare and Medicaid Services (CMS) 7
• Executive Office of the President (EOP) 7
• Food & Drug Administration (FDA) 7
• Homeland Security, Dept of (DHS) 7
• U.S. Trade Representative (USTR) 7

• TEVA PHARMACEUTICAL INDUSTRIES LTD. Israel named on 3 filings · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.